HEADER ANTIVIRAL PROTEIN 31-MAY-10 2XG7 TITLE CRYSTAL STRUCTURE OF BST2-TETHERIN ECTODOMAIN EXPRESSED IN HEK293T TITLE 2 CELLS COMPND MOL_ID: 1; COMPND 2 MOLECULE: BONE MARROW STROMAL ANTIGEN 2; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: ECTODOMAIN, RESIDUES 51-151; COMPND 5 SYNONYM: BST2, TETHERIN, HM1.24 ANTIGEN, CD317; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 8 EXPRESSION_SYSTEM_CELL: HUMAN EMBRYONIC KIDNEY CELLS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHLSEC KEYWDS INNATE IMMUNE FACTOR, ANTIVIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.A.STEINER REVDAT 3 29-JUL-20 2XG7 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 03-NOV-10 2XG7 1 JRNL REVDAT 1 13-OCT-10 2XG7 0 JRNL AUTH H.L.SCHUBERT,Q.ZHAI,V.SANDRIN,D.M.ECKERT,M.GARCIA-MAYA, JRNL AUTH 2 L.SAUL,W.I.SUNDQUIST,R.A.STEINER,C.P.HILL JRNL TITL STRUCTURAL AND FUNCTIONAL STUDIES ON THE EXTRACELLULAR JRNL TITL 2 DOMAIN OF BST2/TETHERIN IN REDUCED AND OXIDIZED JRNL TITL 3 CONFORMATIONS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 17951 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20880831 JRNL DOI 10.1073/PNAS.1008206107 REMARK 2 REMARK 2 RESOLUTION. 3.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0074 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 77.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 5303 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.270 REMARK 3 R VALUE (WORKING SET) : 0.269 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 250 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 391 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.55 REMARK 3 BIN R VALUE (WORKING SET) : 0.3480 REMARK 3 BIN FREE R VALUE SET COUNT : 18 REMARK 3 BIN FREE R VALUE : 0.5280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1209 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 71.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.69000 REMARK 3 B22 (A**2) : 4.06000 REMARK 3 B33 (A**2) : 4.63000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.768 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.507 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.417 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 62.942 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1244 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 828 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1670 ; 1.379 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2035 ; 2.049 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 155 ; 3.194 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 63 ;31.177 ;26.508 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 242 ;15.523 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;14.057 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 199 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1379 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 207 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 72 A 153 REMARK 3 ORIGIN FOR THE GROUP (A): -6.9196 -21.5396 46.2363 REMARK 3 T TENSOR REMARK 3 T11: 0.1359 T22: 0.2967 REMARK 3 T33: 0.3615 T12: -0.1079 REMARK 3 T13: 0.0875 T23: -0.1168 REMARK 3 L TENSOR REMARK 3 L11: 2.0784 L22: 19.2423 REMARK 3 L33: 26.9451 L12: -5.0174 REMARK 3 L13: 5.9350 L23: -22.3376 REMARK 3 S TENSOR REMARK 3 S11: -0.1841 S12: -0.2554 S13: 0.0501 REMARK 3 S21: 0.4704 S22: 0.1969 S23: -0.2837 REMARK 3 S31: -0.4367 S32: -0.5101 S33: -0.0128 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 77 C 151 REMARK 3 ORIGIN FOR THE GROUP (A): -5.3133 -23.4379 40.9578 REMARK 3 T TENSOR REMARK 3 T11: 0.1101 T22: 0.3131 REMARK 3 T33: 0.3638 T12: -0.0038 REMARK 3 T13: -0.0125 T23: -0.0284 REMARK 3 L TENSOR REMARK 3 L11: 0.8241 L22: 30.9815 REMARK 3 L33: 34.9377 L12: 0.4326 REMARK 3 L13: -0.4718 L23: -32.4287 REMARK 3 S TENSOR REMARK 3 S11: -0.2879 S12: -0.0885 S13: -0.0940 REMARK 3 S21: -0.3670 S22: -0.3880 S23: -1.0202 REMARK 3 S31: 0.5108 S32: 0.0598 S33: 0.6759 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. DISORDERED SIDE-CHAINS WERE MODELED STEREOCHEMICALLY REMARK 4 REMARK 4 2XG7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1290044128. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5576 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.450 REMARK 200 RESOLUTION RANGE LOW (A) : 38.950 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3MKX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG8000, 0.1M TRIS-HCL PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 14.43000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.48000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.93000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.48000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 14.43000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.93000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 51 REMARK 465 ALA A 52 REMARK 465 CYS A 53 REMARK 465 ARG A 54 REMARK 465 ASP A 55 REMARK 465 GLY A 56 REMARK 465 LEU A 57 REMARK 465 ARG A 58 REMARK 465 ALA A 59 REMARK 465 VAL A 60 REMARK 465 MET A 61 REMARK 465 GLU A 62 REMARK 465 CYS A 63 REMARK 465 ARG A 64 REMARK 465 ASN A 65 REMARK 465 VAL A 66 REMARK 465 THR A 67 REMARK 465 HIS A 68 REMARK 465 LEU A 69 REMARK 465 LEU A 70 REMARK 465 GLN A 71 REMARK 465 GLU C 51 REMARK 465 ALA C 52 REMARK 465 CYS C 53 REMARK 465 ARG C 54 REMARK 465 ASP C 55 REMARK 465 GLY C 56 REMARK 465 LEU C 57 REMARK 465 ARG C 58 REMARK 465 ALA C 59 REMARK 465 VAL C 60 REMARK 465 MET C 61 REMARK 465 GLU C 62 REMARK 465 CYS C 63 REMARK 465 ARG C 64 REMARK 465 ASN C 65 REMARK 465 VAL C 66 REMARK 465 THR C 67 REMARK 465 HIS C 68 REMARK 465 LEU C 69 REMARK 465 LEU C 70 REMARK 465 GLN C 71 REMARK 465 GLN C 72 REMARK 465 GLU C 73 REMARK 465 LEU C 74 REMARK 465 THR C 75 REMARK 465 GLU C 76 REMARK 465 GLY C 152 REMARK 465 THR C 153 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN C 92 C2 NAG C 201 1.95 REMARK 500 CG ASN C 92 C1 NAG C 201 2.16 REMARK 500 ND2 ASN A 92 O5 NAG A 201 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2X7A RELATED DB: PDB REMARK 900 STRUCTURAL BASIS OF HIV-1 TETHERING TO MEMBRANES BY THE BST2- REMARK 900 TETHERIN ECTODOMAIN DBREF 2XG7 A 51 151 UNP Q10589 BST2_HUMAN 51 151 DBREF 2XG7 C 51 151 UNP Q10589 BST2_HUMAN 51 151 SEQADV 2XG7 GLY A 152 UNP Q10589 EXPRESSION TAG SEQADV 2XG7 THR A 153 UNP Q10589 EXPRESSION TAG SEQADV 2XG7 GLY C 152 UNP Q10589 EXPRESSION TAG SEQADV 2XG7 THR C 153 UNP Q10589 EXPRESSION TAG SEQRES 1 A 103 GLU ALA CYS ARG ASP GLY LEU ARG ALA VAL MET GLU CYS SEQRES 2 A 103 ARG ASN VAL THR HIS LEU LEU GLN GLN GLU LEU THR GLU SEQRES 3 A 103 ALA GLN LYS GLY PHE GLN ASP VAL GLU ALA GLN ALA ALA SEQRES 4 A 103 THR CYS ASN HIS THR VAL MET ALA LEU MET ALA SER LEU SEQRES 5 A 103 ASP ALA GLU LYS ALA GLN GLY GLN LYS LYS VAL GLU GLU SEQRES 6 A 103 LEU GLU GLY GLU ILE THR THR LEU ASN HIS LYS LEU GLN SEQRES 7 A 103 ASP ALA SER ALA GLU VAL GLU ARG LEU ARG ARG GLU ASN SEQRES 8 A 103 GLN VAL LEU SER VAL ARG ILE ALA ASP LYS GLY THR SEQRES 1 C 103 GLU ALA CYS ARG ASP GLY LEU ARG ALA VAL MET GLU CYS SEQRES 2 C 103 ARG ASN VAL THR HIS LEU LEU GLN GLN GLU LEU THR GLU SEQRES 3 C 103 ALA GLN LYS GLY PHE GLN ASP VAL GLU ALA GLN ALA ALA SEQRES 4 C 103 THR CYS ASN HIS THR VAL MET ALA LEU MET ALA SER LEU SEQRES 5 C 103 ASP ALA GLU LYS ALA GLN GLY GLN LYS LYS VAL GLU GLU SEQRES 6 C 103 LEU GLU GLY GLU ILE THR THR LEU ASN HIS LYS LEU GLN SEQRES 7 C 103 ASP ALA SER ALA GLU VAL GLU ARG LEU ARG ARG GLU ASN SEQRES 8 C 103 GLN VAL LEU SER VAL ARG ILE ALA ASP LYS GLY THR MODRES 2XG7 ASN A 92 ASN GLYCOSYLATION SITE MODRES 2XG7 ASN C 92 ASN GLYCOSYLATION SITE HET NAG A 201 14 HET NAG C 201 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE FORMUL 3 NAG 2(C8 H15 N O6) HELIX 1 1 GLN A 72 GLY A 152 1 81 HELIX 2 2 ALA C 77 LYS C 151 1 75 SSBOND 1 CYS A 91 CYS C 91 1555 1555 2.03 LINK ND2 ASN A 92 C1 NAG A 201 1555 1555 1.40 LINK ND2 ASN C 92 C1 NAG C 201 1555 1555 1.43 CRYST1 28.860 91.860 146.960 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.034650 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010886 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006805 0.00000